# A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants

> **NCT07522970** · PHASE1 · NOT_YET_RECRUITING · sponsor: **LinGang Laboratory** · enrollment: 100 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LG-0317
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07522970
- **Lead sponsor:** LinGang Laboratory
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-14
- **Primary completion:** 2026-09-10
- **Final completion:** 2026-09-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07522970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07522970, "A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07522970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*